Temozolomide for melanoma: new toxicities and new opportunities.
Gajewski
Thomas F
TF
D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage / Q000009:adverse effects*; D003606:Dacarbazine / Q000008:administration & dosage / Q000009:adverse effects* / Q000031:analogs & derivatives*; D004334:Drug Administration Schedule; D006801:Humans; D008231:Lymphopenia / Q000139:chemically induced* / Q000517:prevention & control; D008545:Melanoma / Q000188:drug therapy*; D009894:Opportunistic Infections / Q000139:chemically induced* / Q000517:prevention & control; D000077204:Temozolomide
D018906:Antineoplastic Agents, Alkylating; D003606:Dacarbazine; D000077204:Temozolomide